T cell ADCC strategy may expand solid tumor immunotherapy
Engineered CD8+ T cells using FcγRI-mediated ADCC selectively killed tumor cells by sensing antigen density, not antigen identity, in solid cancers.
Therapeutics, diagnostics and evidence shaping cancer care.
Therapeutics, diagnostics and evidence shaping cancer care.